A GP supplied a “well-loved” Islander with a cocktail of “powerful” and “addictive” medication despite knowing that his patient had previously overdosed twice on a similar combination of prescribed drugs, an inquest has heard.
Michael Robert Connor died at his St Brelade flat on 20 February 2025 at the age of 33, after taking “substantial” overdose of legally prescribed medication.
A two-day inquest into his death, held at Morier House, concluded yesterday.
Deputy Viscount and acting coroner Matt Berry found that the Jersey man had been prescribed a month’s worth of opioids and benzodiazepines by his GP upon his release from a spell in custody, despite warnings that he should not be given addictive drugs.
He added that Dr Geoffrey Hamilton, who had been Mr Connor’s GP since 2015, had failed to provide a “clear, clinical explanation” for why he had prescribed the Islander with dihydrocodeine and alprazolam on the day of his release from prison.
Giving evidence at the inquest, Dr Hamilton appeared to accept his record of prescribing Mr Connor addictive medication against the wishes of mental health experts.
It was heard that Mr Connor was admitted to Orchard House in May 2024 after overdosing on prescribed medication, in tandem with cannabis and alcohol.
As a result, his discharge sheet from Orchard House asked that his GP refrain from prescribing addictive medication.
But Mr Berry said that Dr Hamilton had then “almost immediately” prescribed Mr Connor with 28 days’ worth of opiates, contrary to recommendations.
“There probably is an argument I could have gone with more gentle steps in May 2024,” the GP acknowledged. “Particularly in context of him just having an overdose, an instance of overdose at the beginning of May.”
The acting coroner asked him why he had prescribed Mr Connor with four weeks’ worth of medication in May 2024, as opposed to just a one week or two week supply.
“I honestly can’t answer that”, Dr Hamilton answered.
The GP was questioned about his later decision to re-introduce opiates and benzodiazepines – in the form of dihydrocodeine and alprazolam – to Mr Connor’s system following his release from prison in December 2024.
Dr Hamilton responded that Mr Connor had told him he was experiencing severe neck pain, and that he “can only prescribe” what is “being reported” by the patient.
He told the hearing he was not aware that Mr Connor had undergone detoxification from opiates and benzodiazepines while in custody.
He was again asked to explain why he had prescribed the Islander with four weeks’ worth of medication, despite previously taking action to limit his supply to one week’s worth in the wake of Mr Connor’s overdose in May 2024.
Dr Hamilton said he that he had a discussion with Mr Connor, during which he was told that his patient “was going to find it hard to get to a pharmacy” after his release.
In a statement, he further explained that he was unable to access notes made by the prison healthcare team stating that Mr Connor was not to be prescribed “any addictive medications” upon his discharge from prison.
Mr Berry noted that the failure for this information to be relayed to the Dr Hamilton could have been avoided had a single patient record been in place – which would also in turn have better informed Mr Connor’s psychiatrist and care coordinators.
But he ultimately found that the single patient record would still not have prevented Mr Connor from being prescribed the addictive opiates and benzodiazepines.
Mr Berry told the inquest: “As acknowledged in this inquest and in previous ones, the absence of a single patient record, something that the Health Department [is] working to resolve, might have assisted professionals with obtaining a better overall understanding of the prescribing,
“However, even were such an overview available, it is not apparent to me that it would have affected the approach that Dr Hamilton took to prescribing in this case.
“I do not therefore propose to make a report to prevent future deaths, though this case is another timely reminder of the importance of the work on a single patient record and improving information sharing.”
In his narrative conclusion, the acting coroner stated that Mr Connor’s addiction to drugs and alcohol was a “coping mechanism” to deal with his autism and generalised anxiety.
He said that, in view of his drug addiction and dependence, “services were put in place” following his release from prison in 2024 to “support him in the community”.
“However,” he added, “immediately after his release, his GP prescribed him a new combination of benzodiazepines, gabapentinoids and opiates, providing four weeks supply on each prescription.
“He subsequently died of acute cardiorespiratory depression caused by substance-induced toxicity, caused by multi-substance use disorder.”

